-
APOL1 Evolution, Isoforms, and APOL3 Interaction
2026-09-30
Khalaila and Skorecki integrate population-genetic reanalysis, splice-isoform biology, and APOL1–APOL3 interaction data to refine models of APOL1-associated cellular injury. The study highlights variant–haplotype context, isoform-specific physiology, and differential modulation of APOL3 binding by G1 and G2 as complementary priorities for kidney-disease research.
-
AZD0156 Workflows for ATM Kinase Inhibition
2026-09-30
AZD0156 enables selective ATM pathway interrogation in DNA repair, checkpoint, and combination-treatment studies. This practical guide translates evidence from high-grade serous ovarian cancer research into solvent handling, dose-matrix design, pathway readouts, synergy analysis, and troubleshooting strategies.
-
BAPTA-AM Protocol for Intracellular Ca2+ Control
2026-09-29
BAPTA-AM (SKU B4758) provides a cell-permeable way to perturb intracellular Ca2+ during calcium signaling, apoptosis, imaging, and ion-channel experiments. Use it as an experimental calcium chelator with matched vehicle and calcium-response controls; do not interpret results as selective Ca2+ effects without checking magnesium sensitivity, potassium-channel activity, solvent exposure, and assay-specific toxicity.
-
Dual Luciferase Reporter Gene System for MYC2
2026-09-29
Use the Dual Luciferase Reporter Gene System to separate promoter activity from sample-to-sample variation in MYC2-centered regulatory experiments. Its sequential firefly and Renilla readout supports normalization, lysis-free mammalian workflows, and scalable testing of transcriptional brakes and activators.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-28
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is an affinity-purified fluorescent antibody conjugate for detecting rabbit IgG primary antibodies in immunofluorescence, flow cytometry, and fluorescence microscopy. It should not be assumed suitable for non-rabbit primary antibodies, unvalidated quantitative multiplexing, or live-cell exposure without compatibility testing.
-
APOL1 Evolution, Isoforms, and APOL3 Interaction
2026-09-28
Khalaila and Skorecki integrate population-genetic analysis with findings on APOL1 splice isoforms and APOL1–APOL3 interaction to refine questions about how APOL1 risk variants may contribute to kidney-cell injury. Their work emphasizes that haplotype context, isoform-specific properties, and protein interactions should be examined together rather than treating APOL1 variants as isolated factors.
-
β-Pseudouridine Workflows for RNA Research
2026-09-27
Use β-Pseudouridine as an analytical reference and mechanistic probe for RNA modification—not as a drop-in substrate for RNA transcription. A careful workflow can connect RNA structure and translational-fidelity assays to emerging self-amplifying RNA research while keeping reagent chemistry separate from vaccine-platform performance.
-
Prednisolone in Signaling and ERAD Research
2026-09-26
Use Prednisolone as a controlled glucocorticoid stimulus to map receptor-dependent inflammatory responses, then compare those signaling readouts with the distinct protein-degradation strategy of ERAD-engaging chimeras. Practical dosing, solvent, timing, and control recommendations help separate corticosteroid activity from targeted membrane-protein degradation.
-
ONX-0914: Reading Immunoproteasome Biology Beyond Cytokines
2026-09-25
ONX-0914 (PR-957) is a selective LMP7 inhibitor used to investigate immune signaling. This article connects immunoproteasome perturbation to interferon-driven antiviral biology—and explains how to test that connection without treating a mechanistic clue as proof of drug activity.
-
VX-745: A Selective p38α MAPK Inhibitor
2026-09-25
VX-745 offers a useful way to probe p38α-dependent inflammatory signaling, with reported 10 nM biochemical potency and applications spanning cytokine assays, stromal-cell biology, and multiple myeloma research. This workflow pairs standard target-engagement measurements with a careful test of a newer idea: kinase inhibitors may also alter how readily p38α is dephosphorylated.
-
Potent Pyrimidine Inhibitors of TSSK2
2026-09-24
Hawkinson and colleagues used a mobility-shift high-throughput screen to identify pyrrolopyrimidine and pyrimidine inhibitors of the sperm-associated kinase TSSK2, including compounds with sub-100 nM biochemical potency. Their results establish useful chemical starting points for studying TSSK biology and reversible male contraception, while highlighting the need to test isoform coverage, cellular activity, and contraceptive efficacy.
-
Lipid Peroxidation (MDA) Assay Kit in Ferroptosis
2026-09-24
The Lipid Peroxidation (MDA) Assay Kit can quantify a downstream footprint of membrane oxidation—but MDA is not, by itself, proof of ferroptosis. This article uses recent ccRCC resistance research to explain how to interpret MDA alongside pathway and cell-fate measurements.
-
Lysosomal β-Galactosidase Staining Kit for HNSCC
2026-09-23
Use this X-gal assay to visualize lysosomal acidic β-galactosidase as a control readout in HNSCC senescence and cisplatin-resistance experiments—not as a stand-alone senescence diagnosis. Its polystyrene-compatible workflow complements, rather than replaces, molecular and functional assays of SLC25A1-driven resistance.
-
KIR2.1, TGF-β Signaling, and Pulmonary Vascular Remodeling
2026-09-23
A 2022 study linked KIR2.1 activity to PDGF-BB-induced pulmonary artery smooth muscle cell proliferation and migration through the TGF-β1/SMAD2/3 pathway. Its combined rat model and human-cell experiments position KIR2.1 as a potential regulator of pulmonary vascular remodeling while showing that pathway blockade can suppress downstream cellular responses.
-
Tamsulosin and Ureteral Stone Passage: Evidence Review
2026-09-22
This systematic review and meta-analysis reconciled conflicting clinical trials by pooling evidence on tamsulosin for symptomatic ureteral stones. The findings support higher stone-expulsion rates and shorter passage times without a significant increase in overall adverse effects, while also highlighting heterogeneity that matters for clinical and translational interpretation.